Daniele Andreini
Researcher
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
May 25, 2026
Journal editorial: Beyond ischemia and anatomy: functional capacity as a stage-specific prognostic driver in advanced coronary atherosclerosis
4:41
5:05
6:59

Daniele AndreiniGUEST
So, uh, the results of the study show very well that even when we already know how many vessel are diseased with, uh, plaque or even critical stenosis, the, the peak exercise capacity expresses as, uh, peak metabolic equivalent still remains an independent and strong predictor or all-cause mortality, but also cardiovascular mortality.

Daniele AndreiniGUEST
So then the, the, the exercise capacity is independent from the anatomical results that we can found at CT or at invasive assessment.

Edoardo ConteHOST
But, uh, just to, um, go towards the conclusion, uh, is that correct to conclude that CCTA and anatomical evaluation is no more important, or it's a, a term of, uh, defining w- the best tool for the, the appropriate stage of disease? Daniele, what do you think?